Case File
efta-efta01770828DOJ Data Set 10CorrespondenceEFTA Document EFTA01770828
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01770828
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
W. Ian Lipkin
Sent:
Wednesday, January 4, 2012 9:18 PM
To:
Jeffrey Epstein
Subject:
Re: Contact
Thanks. My cell number is ian
W. Ian Lipkin, MD
John =now Professor of Epidemiology and Director Center for Infection =nd Immunity Mailman School of Public Health
Professor of =athology and Neurology
College of Physicians & =urgeons
Columbia University
A=ministrative Coordinator
John Hal in
Email
Follow CII on Twitter: CII722 I Facebook: Center =or Infection and =mmunity
=/span>
On Jan 4, 2012, at 4:09 PM, Jeffrey Epstein =rote:
i will be back first week of feb " lets try to get =ogether then
On Wed, Jan 4, 2012 at =:52 AM, W. Ian Lipkin <[email protected]> =rote:
Dear Mr. Epstein,
Ellis Rubinstein tried to introduce us in October but failed due to the =omplexity of coordinating 3
calendars. I'm following up at his ìommendation with the hope that we may find it easier to meet =irectly. I direct the
largest and most productive center for pathogen =urveillance and discovery. Housed at Columbia, the Center for
PROT2
PROT0
Infection =nd Immunity and associated WHO Collaborating Centre, is poised to =xpand from metagenomic and zoonotic
diseases research to address the =ole of gene-environment-timing interactions in neurodevelopmental, =eoplastic and
autoimmune disorders. The strategies and tools needed to =o this are largely the same; thus, I'm confident this new
initiative =an succeed and have a huge impact on human morbidity and mortality. =lease suggest a date and time we can
meet to discuss your vision for =asic and translational public health and see whether a collaboration =akes sense.
All best wishes,
Ian Lipkin
The =nformation contained in this communication is confidential, may be =ttorney-client privileged, may
constitute inside information, and is intended only for the use of =he addressee. It is the property of
Jeffrey Epstein
Unauthorized =se, disclosure or copying of this communication or any part thereof =s strictly prohibited
and may be unlawful. If you have received this communication in =rror, please notify us immediately by
return e-mail or by e-mail to =a href="mailto:[email protected]"
=arget="_blank">[email protected], and destroy this communication and all copies thereof,
including all =ttachments. copyright -all rights reserved
2
PROT3
PROT1
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.